Bausch Health Companies Inc BHC
$5.69
+0.71%
at last close
Market Cap$2.13 billion
P/E Ratio—
Div Yield—
Volume1.25M
52-Week Range
$4.33$8.00
Analyst Ratings
- Consensus
- Hold — 0 Buy · 3 Hold · 0 Sell (3 analysts)
- Avg. Price Target
- $8.00 (+40.6% upside)
Key Stats
- Today's Range
- $5.63 – $5.83
- 50-Day Range
- $4.33 – $7.30
- 52-Week Range
- $4.33 – $8.00
- Volume
- 1.25 million shs
- Average Volume
- 2.54 million shs
- Market Cap
- $2.13 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- -2.65
- Price / Sales
- 0.20
Short Interest
- Short Interest
- 3.80%
- Days to Cover
- 4.27
Financials (TTM)
- Revenue
- $10.85 billion
- Net Income
- $-1,093,000,000
- Net Margin
- -10.07%
- Return on Equity
- 136.28%
- Debt-to-Equity
- -25.86
About Bausch Health Companies Inc
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
Related Stocks
Compare head-to-head: BHC vs LLY·BHC vs JNJ·BHC vs ABBV·BHC vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.